Last updated on February 2018

Real World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Brief description of study

Prospective study to quantify the prevalence of possible tardive dyskinesia (TD) in outpatient psychiatry practices in the United States (US), as well as to describe the associated disease burden in a cohort of patients with one or more psychiatric disorders and a cumulative lifetime exposure to antipsychotic medication of three months or more.

Clinical Study Identifier: NCT03062033

Find a site near you

Start Over

Neurocrine Clinical Site

Garfield Heights, OH United States
  Connect »